We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Orthopedic bone graft developer Cerapedics Inc. has raised $19mm through its Series C financing round led by first-time investors MedImmune Ventures (adds a board member) and CVF LLC, which were joined by former backers OrbiMed Advisors and NGN Capital, and one undisclosed investor. The money will fund the ongoing IDE trial in the US of its i-FACTOR peptide-enhanced bone graft for cervical spine applications and to prep for the eventual commercialization. Funds will also support development of next-generation products and ex-US sales and marketing activities of i-FACTOR.
Deal Industry
Medical Devices
Medical Devices
Biomaterials
Implantable Devices
Biotechnology
Large Molecule
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?